- Patients and Families
- About Alpha-1
- Testing for Alpha-1
- ARALAST Therapy
- Insurance Assistance
- Help and Support
Insurance Support
Insurance coverage is often an issue of concern for Alphas and their families. Baxter offers services specifically designed to assist you with these issues.
Baxter is pleased to provide the ARA-ASSIST Program, a way for eligible users of Baxter’s ARALAST to continue to receive their ARALAST without charge in the event of a lapse in private insurance.
Baxter's Department of Healthcare Economics offers education, support, and advocacy to patients and their healthcare providers, acting as a resource to those who rely on our therapies.
Patient Services Incorporated (PSI) is a non-profit organization, supported by Baxter, which may offer you help with billing and reimbursement issues.
ARALAST is available through a network of Specialty Pharmacies. One of the services offered by specialty pharmacies is assistance with reimbursement and insurance issues.
If you have no insurance and are financially disadvantaged, you may qualify to receive ARALAST for a limited time through Baxter upon eligibility. For information please call the Baxter Insurance Helpline 1-866-ARALAST (1-866-272-5278).
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
| To view PDF, you will need Adobe® Acrobat® Reader® software. |
